ImmuVia develops novel antibody-based targeted therapeutics to treat oncological diseases. Founded in 2017, ImmuVia works on developing cutting-edge therapeutic products that will make a difference in patients’ lives.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Cambridge , Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.immuviatx.com
- HQ
- Cambridge
Immuvia Questions
Immuvia's website is http://www.immuviatx.com
Immuvia's LinkedIn profile is https://www.linkedin.com/company/immuvia
Immuvia has
2 employees.
View email and phone details for 2
employees at Immuvia.
Immuvia's industry is
Biotechnology Research
Immuvia's top competitors are
Abalytics Oncology,
Poseida Therapeutics, Inc.,
Lifespan News,
Extractas Bioscience,
Eyedaptic,
Chemeleon,
Immunogen, Inc.,
Triveni Bio,
Forbius,
Abbvie.
Immuvia's categories are Biotechnology Research
Immuvia's founding year is 2017
